{"id":204481,"date":"2026-08-14T14:21:49","date_gmt":"2026-08-14T08:51:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=204481"},"modified":"2026-08-14T14:21:49","modified_gmt":"2026-08-14T08:51:49","slug":"why-natco-pharma-ltd-share-price-fall-2026-08-14","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-fall-2026-08-14\/","title":{"rendered":"Natco Pharma Ltd. (NATCOPHARM): Natco Pharma Share Price Falls 5.63% Today; Healthcare Stock Turns Top Decliner"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma Ltd.<\/a> fell to Rs 898.60, down 5.63% today, with market capitalisation at Rs 16,388.55 crore and total traded volume of 8,98,526 shares.<\/p>\n<p style=\"margin-top:0!important;\">Natco Pharma Share Price fell sharply in Friday trade, with the stock at Rs 898.60 at 2:17:07 PM IST, down Rs 53.65 or 5.63% from the previous close of Rs 952.25. With a market capitalisation of Rs 16,388.55 crore, the company remains a notable mid-cap name in the Healthcare space, and today\u2019s move was large enough to place it on a price-fall threshold screen tracking significant single-session declines.<\/p>\n<p>For traders scanning Stock Market Today and Share Market Today, the move stands out because the stock opened at Rs 952.25, touched a high of Rs 962.25, and then weakened to an intraday low of Rs 891.15 before trading near Rs 898.60. That sequence points to a session in which early levels did not hold and selling pressure intensified as the day progressed. The supplied data confirms the price event but does not establish a company-specific catalyst behind the decline.<\/p>\n<p>Natco Pharma Share Price Today is therefore trending not because of a verified announcement in the supplied data, but because the size of the fall, the turnover of Rs 6.67 crore and total volume of 8,98,526 shares made it one of the more visible market movers in Healthcare. In this Univest analysis, the focus is on what the price action shows, how the stock compares with the sector benchmark and peers, and what investors may want to monitor next in Natco Pharma Stock News.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Natco_Pharma_Ltd_NATCOPHARM_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Natco Pharma Ltd. (NATCOPHARM) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 898.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 952.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -53.65 (-5.63%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 952.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 962.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 891.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">74,171<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">74,171<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8,24,355<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8,98,526<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6.67 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,388.55 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Ltd. (NATCOPHARM) traded at Rs 898.6. versus the previous close of Rs 952.25, a fall of 5.63%. The stock opened at Rs 952.25, reached Rs 962.25, touched Rs 891.15. Reported volume was 74,171.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Natco_Pharma_Ltd_NATCOPHARM_Fundamental_Analysis\"><\/span><strong>Natco Pharma Ltd. (NATCOPHARM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,388.55 crore<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Fundamental Analysis in the supplied data begins with size and market standing rather than a full company financial ratio set. The stock\u2019s market capitalisation is Rs 16,388.55 crore, which places it well above the median and average market capitalisation figures in the supplied Healthcare benchmark universe. That matters because market capitalisation indicates company size, and Natco Pharma Share Price is being evaluated in the context of a much larger company than many of the benchmark names included in the same-sector screen.<\/p>\n<p>The current session also provides a useful market-based financial lens. A turnover of Rs 6.67 crore and total traded volume of 8,98,526 shares show that today\u2019s price discovery was based on active participation. For investors following Natco Pharma Share Price Today and Natco Pharma Stock News, liquidity matters because a move of 5.63% accompanied by visible traded value carries more informational weight than a similar move on extremely thin volume.<\/p>\n<p>The available data does not present company-specific P\/E, P\/B, ROE, ROCE, EPS, book value, dividend yield, leverage or cash-generation numbers for Natco Pharma Ltd., so the fundamental context here is drawn from what can be verified directly: a mid-cap Healthcare company with a market value of Rs 16,388.55 crore that recorded a meaningful single-session price fall and is now being judged against the valuation and profitability backdrop of its sector and peers. That makes sector comparison especially important in Natco Pharma Fundamental Analysis, because the stock\u2019s relevance today comes not only from the decline itself but also from where the company sits in the broader Healthcare landscape. Univest therefore shifts from the day\u2019s tape to the sector\u2019s benchmark statistics and peer dispersion before framing what investors should watch next.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.2x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">75.33x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.29x to 3,299.57x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.07%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,388.55 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 141.55 crore<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Ltd. (NATCOPHARM) is classified under sector: Healthcare.<\/p>\n<p>Track today&#8217;s top decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>Natco Pharma Share Price is moving within the Healthcare sector, and the supplied same-sector benchmark provides an important frame for interpreting today\u2019s decline. Across 196 benchmark companies, the Healthcare universe shows a wide spread in valuation, profitability and size, which means a single-day fall should be read against a broad sector backdrop rather than in isolation.<\/p>\n<p>The sector benchmark covers 196 companies on a same-sector basis. Within that sample, the median P\/E is 26.2 and the average P\/E is 75.33 across 156 companies, while the range runs from 3.29 to 3,299.57. That very wide dispersion suggests the Healthcare basket includes both modestly valued businesses and names trading at much richer multiples. On price-to-book, the median is 1.96 and the average is 2.65 across 195 companies, with a range from -10.01 to 16.63. Profitability is similarly dispersed: median ROE is 11.07 and average ROE is 15.46 across 195 companies, while median ROCE is 13.35 and average ROCE is 17.73 across 195 companies.<\/p>\n<p>Size dispersion is also substantial. The benchmark median market capitalisation is Rs 141.55 crore and the average is Rs 465.17 crore, while the range stretches from Rs 3.67 crore to Rs 2,995.34 crore. Against that, Natco Pharma Share Price represents a company with a market capitalisation of Rs 16,388.55 crore, far above the maximum market-cap figure shown in the supplied benchmark list. That does not by itself say anything about quality or valuation, but it does show that the company\u2019s market size is materially larger than the displayed same-sector comparables. For Univest readers, this is a key part of the stock analysis: today\u2019s share price fall happened in a Healthcare universe where both valuation and profitability vary widely, but the company\u2019s market scale is clearly at the upper end relative to the supplied benchmark set.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,995.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,836.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">69.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,644.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,619.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,605.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">45.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Ltd. (NATCOPHARM) has a market capitalisation of Rs 16,388.55 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<p>Natco Pharma Share Price can also be viewed through the lens of the supplied peer set, which includes listed Healthcare names across Pharmaceuticals &amp; Drugs and Hospital &amp; Healthcare Services. The main takeaway is not a one-line ranking, but the spread in valuation and returns across peers and the difference in company size between Natco Pharma Ltd. and the displayed comparison group.<\/p>\n<p>On market capitalisation, Natco Pharma Ltd. at Rs 16,388.55 crore is substantially larger than every supplied peer. Dishman Carbogen Amcis Ltd. stands at Rs 2,995.34 crore, Beta Drugs Ltd. at Rs 2,836.87 crore, Dr Agarwals Eye Hospital Ltd. at Rs 2,644.55 crore, Hikal Ltd. at Rs 2,619.52 crore and Ind-Swift Laboratories Ltd. at Rs 2,605.37 crore. The remaining displayed peers are still smaller, ranging down to Venus Remedies Ltd. at Rs 2,214.91 crore. From a market-size standpoint, Natco Pharma Share Price therefore sits outside the core band of the peer basket shown here.<\/p>\n<p>Valuation and return metrics in the peer group are mixed. Dishman Carbogen Amcis trades at a P\/E of 31.94 with ROE of -2.89 and ROCE of -0.26. Beta Drugs carries a P\/E of 69.35, P\/B of 10.97, ROE of 18.65 and ROCE of 22.17. Dr Agarwals Eye Hospital shows a P\/E of 34.7, P\/B of 7.15, ROE of -2.6 and ROCE of 16.92. Ind-Swift Laboratories is at 45.02 times earnings with P\/B of 1.73, ROE of -0.78 and ROCE of 8.31. Sai Parenteral&#8217;s stands out with a P\/E of 174.73, while Fredun Pharmaceuticals is at 56.53 and Venus Remedies at 19.99.<\/p>\n<p>The peer data shows a broad range of profitability outcomes, from negative ROE and ROCE in some companies to stronger return profiles in others such as Beta Drugs and Solara Active Pharma Sciences, where ROE is 17.23 and ROCE is 15.34. In practical terms, Natco Pharma Share Price is being watched today because its 5.63% decline occurred in a sector where peers already trade on very different earnings and return profiles. Without company-specific valuation ratios in the supplied dataset, the cleanest verified conclusion is that the stock belongs to a much larger market-cap bracket than the peer names shown, while the wider Healthcare space remains highly varied on both valuation and capital efficiency.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Natco_Pharma\"><\/span><strong>Why Investors Are Watching Natco Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Natco Pharma Share Price is in focus because today\u2019s decline was significant enough to trigger event-based market screens and because the stock combines visible liquidity, sizeable market capitalisation and sector relevance. For anyone scanning Top Losers Today, Stocks Falling Today or market movers within Healthcare, the session offered a clear data-led reason to monitor the stock closely.<\/p>\n<ul>\n<li><strong>Price action:<\/strong> The stock fell 5.63% to Rs 898.60 from Rs 952.25, with an intraday high of Rs 962.25 and low of Rs 891.15.<\/li>\n<li><strong>Volume participation:<\/strong> Total traded volume reached 8,98,526 shares, including 8,24,355 on NSE and 74,171 on BSE, with turnover of Rs 6.67 crore.<\/li>\n<li><strong>Market position:<\/strong> Natco Pharma Ltd. remains a Mid Cap stock with market capitalisation of Rs 16,388.55 crore.<\/li>\n<li><strong>Sector context:<\/strong> The company sits in Healthcare, where benchmark valuation and profitability ranges are wide across 196 companies.<\/li>\n<li><strong>Peer framing:<\/strong> The supplied peer group is materially smaller in market-cap terms, even though its valuation and ROE\/ROCE dispersion is broad.<\/li>\n<\/ul>\n<p>What investors may monitor next is whether Natco Pharma Share Price continues to trade near the day\u2019s lower zone or stabilises relative to recent price action, how future sessions compare on volume participation, and whether the stock\u2019s position in Mid Cap Healthcare screens persists. Univest would also watch how the stock compares with sector and peer movement, because today\u2019s decline is verified, while the company-specific reason is not established in the supplied data.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Natco_Pharma\"><\/span><strong>About Natco Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Natco Pharma Ltd. is being covered here strictly through the verified market data supplied for this event. The company trades under the symbol NATCOPHARM and is categorised within the Healthcare sector. In market-structure terms, that places Natco Pharma Share Price in one of the most closely tracked segments of the Indian Stock Market, a sector where valuation, profitability and company size vary widely across listed names.<\/p>\n<p>The broader same-sector comparison in this dataset spans 196 companies and includes businesses from Pharmaceuticals &amp; Drugs as well as Hospital &amp; Healthcare Services. That gives useful context for Natco Pharma Stock Analysis even without extending beyond the supplied figures. Healthcare as a listed sector includes companies with sharply different P\/E ratios, P\/B multiples, ROE and ROCE profiles, suggesting that investors often distinguish between businesses on the basis of operating model, profitability and market scale rather than applying a single sector-wide template.<\/p>\n<p>Within that listed-market context, Natco Pharma Ltd. stands out for size alone, with a market capitalisation of Rs 16,388.55 crore, well above the benchmark median of Rs 141.55 crore and average of Rs 465.17 crore. For readers following Natco Pharma Share Price Live, Natco Pharma Latest News and Natco Pharma Company News, that means the stock occupies a larger market footprint than many displayed Healthcare names and can draw attention quickly when it becomes a top decliner in a single session. Univest tracks such moves by combining price action, sector statistics and peer dispersion into a single factual market update.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Natco_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Natco Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma Ltd. (NATCOPHARM) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners lists and related market analysis.<\/p>\n<p>Investors using Univest can track Natco Pharma Share Price through a data-led market view that brings together intraday price action, traded volume, market capitalisation, sector context and peer comparison in one place. That helps readers follow Natco Pharma Share Price Today without relying only on the headline percentage move.<\/p>\n<p>On Univest, users can monitor share price updates, market insights, 52-week levels when available, technical indicators when supplied, fundamental ratios when reported, shareholding pattern where disclosed, and broader sector positioning. For a stock like Natco Pharma Ltd., which entered focus after a 5.63% decline, a structured dashboard helps separate what is verified in the day\u2019s data from what still needs confirmation in subsequent Natco Pharma Stock News and market updates.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Natco_Pharma_Share_Price_today\"><\/span><strong>What is Natco Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price was Rs 898.60 at 2:17:07 PM IST on 14 August 2026. The stock was down Rs 53.65 from the previous close of Rs 952.25, making it a notable Healthcare decliner today.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Natco_Pharma_Share_Price_falling_today\"><\/span><strong>Why is Natco Pharma Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied market data confirms that Natco Pharma Share Price fell 5.63% in today\u2019s session and entered a price-fall threshold screen. However, the verified dataset establishes the move itself, not a company-specific catalyst for the decline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Natco_Pharma_Share_Price_decline_today\"><\/span><strong>How much did Natco Pharma Share Price decline today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price declined by Rs 53.65, or 5.63%, from the previous close of Rs 952.25 to Rs 898.60. That magnitude made the stock stand out among today\u2019s Healthcare market movers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_day_high_and_day_low_for_Natco_Pharma\"><\/span><strong>What were the day high and day low for Natco Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In today\u2019s session, Natco Pharma Share Price opened at Rs 952.25, rose to a day high of Rs 962.25, and later slipped to a day low of Rs 891.15. The stock was trading near the lower end of that range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Natco_Pharma_Ltd\"><\/span><strong>What is the market capitalisation of Natco Pharma Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Ltd. had a market capitalisation of Rs 16,388.55 crore at the time of this update. That places the stock in the Mid Cap category and well above the supplied Healthcare benchmark\u2019s median size.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_volume_was_traded_in_Natco_Pharma_today\"><\/span><strong>How much volume was traded in Natco Pharma today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Total traded volume in Natco Pharma stood at 8,98,526 shares. Of this, 8,24,355 shares were traded on NSE and 74,171 shares on BSE, while the reported turnover for the session was Rs 6.67 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Natco_Pharma_in_NSE_and_BSE_trading_today\"><\/span><strong>Is Natco Pharma in NSE and BSE trading today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. The supplied data shows trading activity for Natco Pharma on both exchanges today. NSE volume was 8,24,355 shares, while BSE volume was 74,171 shares, confirming active participation across both venues.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_does_Natco_Pharma_belong_to\"><\/span><strong>Which sector does Natco Pharma belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Ltd. is classified in the Healthcare sector in the supplied dataset. The same-sector benchmark used in this article covers 196 companies, showing broad variation in valuation, profitability and market capitalisation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Natco_Pharma_compare_with_the_Healthcare_benchmark_on_size\"><\/span><strong>How does Natco Pharma compare with the Healthcare benchmark on size?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma\u2019s market capitalisation is Rs 16,388.55 crore, while the Healthcare benchmark median is Rs 141.55 crore and average is Rs 465.17 crore. That means the company is much larger than the displayed same-sector benchmark norms.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Natco_Pharma_in_focus_on_Univest_today\"><\/span><strong>Why is Natco Pharma in focus on Univest today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price is in focus on Univest because the stock fell 5.63%, traded 8,98,526 shares, logged turnover of Rs 6.67 crore and appeared in a price-fall event screen for Mid Cap stocks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Natco Pharma Ltd. Share Price rises to Rs Rs 898.6. marking a 5.63% rise today. clearing the 5% threshold for Mid Cap stocks. Market cap stands at Rs 16,388.55<\/p>\n","protected":false},"author":29,"featured_media":204480,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-204481","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["204480"],"rank_math_title":["Natco Pharma Share Price Falls 5.63%: Price, Sector View"],"rank_math_description":["Natco Pharma Share Price Fall puts the stock in focus today. Track price, volume, market capitalisation, sector snapshot and peer comparison."],"rank_math_focus_keyword":["Natco Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Natco_Pharma_Ltd_NATCOPHARM_Natco_Pharma_Share_Price_Falls_563_Today_Healthcare_Stock_Turns_Top_Decliner_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/204481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=204481"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/204481\/revisions"}],"predecessor-version":[{"id":204482,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/204481\/revisions\/204482"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/204480"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=204481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=204481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=204481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}